BAAM
ANAC

Baker Avenue Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Baker Avenue Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,070
Closed -$238K – 269
2015
Q2 		$238K Sell
3,070
-1,300
-30% -$85.2K 0.03% 219
2015
Q1 		$253K Sell
4,370
-5,630
-56% -$239K 0.03% 200
2014
Q4 		$323K Hold
10,000
– – 0.04% 207
2014
Q3 		$245K Buy
+10,000
New +$203K 0.03% 228

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Baker Avenue Asset Management's ANAC Position: Q3 2015 in Review

Baker Avenue Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 3,070 shares — an estimated $238K sold.

Baker Avenue Asset Management first reported a position in ANAC in Q3 2014 and held it in 4 quarters. The position peaked at $323K in Q4 2014. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Baker Avenue Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Baker Avenue Asset Management sold 3,070 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $238K.
  • Baker Avenue Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 4 quarters.
  • Baker Avenue Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $323K in Q4 2014.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Baker Avenue Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.